Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pan FGFR kinase inhibitor BGJ398
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
BGJ398 and Imatinib Mesylate in Treating Patients with Untreated Advanced Gastrointestinal Stromal Tumor
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-140, NCI-2014-02117, NCT02257541
A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398X2201, NCI-2014-00150, NCT01975701
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CBGJ398X2204, NCI-2014-01310, 2013-005085-19, NCT02150967
LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CLGX818X2109, NCI-2015-00412, NCT02159066
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398XUS04, NCI-2014-01999, NCT02160041
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398X2101, NCI-2011-01165, 2009-010876-73, NCT01004224
Phase 1b Trial of BGJ398/BYL719 in Solid Tumors
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398X2102, NCI-2013-01763, NCT01928459
Start Over